Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziz Zaanan

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 14, 2026
Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: A retrospective study by AGEOEmeric Boisteau, Alice Boilève, David Tougeron, et al.
JNCI Cancer Spectrum|September 29, 2023
Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter studyAziz Zaanan, Julie Henriques, Anthony Turpin, et al.
Nature Medicine|March 17, 2026
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trialKohei Shitara, Hirokazu Shoji, Nicola Fazio, et al.
International Journal of Cancer|December 23, 2022
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO studyMarie Auvray Kuentz, Vincent Hautefeuille, Louis de Mestier, et al.
Journal of the National Cancer Institute|August 20, 2025
Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: the RASINTRO prospective multicenter studyAziz Zaanan, Elisabeth Sophie Bergen, Ludovic Evesque, et al.
International Journal of Cancer|November 13, 2020
Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohortThomas Aparicio, Magali Svrcek, Julie Henriques, et al.
Cancer|June 9, 2015
Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues OncologuesBertrand Brieau, Laetitia Dahan, Yann De Rycke, et al.
Cancer Medicine|June 16, 2023
Prognostic value of Lynch syndrome, BRAF<sup>V600E</sup> , and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohortsKoen Zwart, Frederieke H van der Baan, Romain Cohen, et al.
The Oncologist|June 2, 2019
Characteristics of <i>BRAF</i><sup></sup> Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 PatientsChristelle de la Fouchardière, Romain Cohen, David Malka, et al.
JCO Precision Oncology|September 14, 2020
Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 TrialsAziz Zaanan, Qian Shi, Julien Taieb, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|April 14, 2026
Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: A retrospective study by AGEOEmeric Boisteau, Alice Boilève, David Tougeron, et al.
JNCI Cancer Spectrum|September 29, 2023
Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter studyAziz Zaanan, Julie Henriques, Anthony Turpin, et al.
Nature Medicine|March 17, 2026
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trialKohei Shitara, Hirokazu Shoji, Nicola Fazio, et al.
International Journal of Cancer|December 23, 2022
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO studyMarie Auvray Kuentz, Vincent Hautefeuille, Louis de Mestier, et al.
Journal of the National Cancer Institute|August 20, 2025
Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: the RASINTRO prospective multicenter studyAziz Zaanan, Elisabeth Sophie Bergen, Ludovic Evesque, et al.
International Journal of Cancer|November 13, 2020
Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohortThomas Aparicio, Magali Svrcek, Julie Henriques, et al.
Cancer|June 9, 2015
Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues OncologuesBertrand Brieau, Laetitia Dahan, Yann De Rycke, et al.
Cancer Medicine|June 16, 2023
Prognostic value of Lynch syndrome, BRAF<sup>V600E</sup> , and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohortsKoen Zwart, Frederieke H van der Baan, Romain Cohen, et al.
The Oncologist|June 2, 2019
Characteristics of <i>BRAF</i><sup></sup> Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 PatientsChristelle de la Fouchardière, Romain Cohen, David Malka, et al.
JCO Precision Oncology|September 14, 2020
Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 TrialsAziz Zaanan, Qian Shi, Julien Taieb, et al.
Pageof 13